PDF herunterladen
Semin intervent Radiol 2019; 36(02): 072-075
DOI: 10.1055/s-0039-1688418
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Hemolytic Anemia following Stent-Graft Transjugular Intrahepatic Portosystemic Shunt Creation

Andrew Kuei
1   Department of Radiology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois
,
Adam E. Mikolajczyk
2   Division of Gastroenterology and Hepatology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois
,
Matthew M. Niemeyer
1   Department of Radiology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois
3   Division of Interventional Radiology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
22. Mai 2019 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Transjugular intrahepatic portosystemic shunt (TIPS) creation is a minimally invasive technique aimed at managing the complications of portal hypertension. Initially performed in the setting of variceal bleeding, the role of TIPS has expanded to treatment of medically refractory ascites, portal hypertensive gastropathy, hepatic hydrothorax, Budd-Chiari syndrome, portal vein thrombus, and hepatorenal syndrome. Potential complications from TIPS are well documented, and include hepatic encephalopathy, hepatic failure, and TIPS dysfunction. Hemolytic anemia is a lesser known complication related to TIPS creation. In this article, a case of hemolytic anemia following TIPS creation using a Viatorr stent-graft in described.

Keywords

TIPS - hemolytic anemia - e-PTFE - interventional radiology

Disclosure

A.K., A.E.M., and M.M.N. have nothing to disclose.


 

  • References

  • 1 Richter GM, Palmaz JC, Nöldge G. , et al. [The transjugular intrahepatic portosystemic stent-shunt. A new nonsurgical percutaneous method]. Radiologe 1989; 29 (08) 406-411
    PubMedSuche in Google Scholar
  • 2 Yang Z, Han G, Wu Q. , et al. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis. J Gastroenterol Hepatol 2010; 25 (11) 1718-1725
    CrossrefPubMedSuche in Google Scholar
  • 3 Saad WE. The history and future of transjugular intrahepatic portosystemic shunt: food for thought. Semin Intervent Radiol 2014; 31 (03) 258-261
    Thieme ConnectPubMedSuche in Google Scholar
  • 4 Copelan A, Kapoor B, Sands M. Transjugular intrahepatic portosystemic shunt: indications, contraindications, and patient work-up. Semin Intervent Radiol 2014; 31 (03) 235-242
    Thieme ConnectPubMedSuche in Google Scholar
  • 5 Suhocki PV, Lungren MP, Kapoor B, Kim CY. Transjugular intrahepatic portosystemic shunt complications: prevention and management. Semin Intervent Radiol 2015; 32 (02) 123-132
    Thieme ConnectPubMedSuche in Google Scholar
  • 6 Sanyal AJ, Freedman AM, Purdum PP, Shiffman ML, Luketic VA. The hematologic consequences of transjugular intrahepatic portosystemic shunts. Hepatology 1996; 23 (01) 32-39
    CrossrefPubMedSuche in Google Scholar
  • 7 Sanyal AJ, Freedman AM, Purdum III PP. TIPS-associated hemolysis and encephalopathy. Ann Intern Med 1992; 117 (05) 443-444
    PubMedSuche in Google Scholar
  • 8 Cheng KH, Laméris JS, de Man RA, Pieterman H, van Buuren HR. Haemolysis and cholestasis following implantation of a transjugular intrahepatic portosystemic shunt. Eur J Gastroentrology Hepatology 1994; 6 (08) 749-752
    PubMedSuche in Google Scholar
  • 9 Riggio O, Ricci G, Zullo A. , et al. Intravascular hemolysis and transjugular intrahepatic portosystemic stent shunt. J Hepatol 1994; 20 (01) 152-153
    PubMedSuche in Google Scholar
  • 10 Conn HO. Hemolysis after transjugular intrahepatic portosystemic shunting: the naked stent syndrome. Hepatology 1996; 23 (01) 177-181
    CrossrefPubMedSuche in Google Scholar
  • 11 Brodeur MTH, Sutherland DW, Koler RD, Starr A, Kimsey JA, Griswold HE. Red blood cell survival in patients with aortic valvular disease and ball-valve prostheses. Circulation 1965; 32 (04) 570-581
    CrossrefPubMedSuche in Google Scholar
  • 12 Nevaril CG, Lynch EC, Alfrey Jr CP, Hellums JD. Erythrocyte damage and destruction induced by shearing stress. J Lab Clin Med 1968; 71 (05) 784-790
    PubMedSuche in Google Scholar
  • 13 Gottlieb Y, Topaz O, Cohen LA. , et al. Physiologically aged red blood cells undergo erythrophagocytosis in vivo but not in vitro. Haematologica 2012; 97 (07) 994-1002
    CrossrefPubMedSuche in Google Scholar
  • 14 Garcia-Rebollo S, González-Reimers E, Santolaria-Fernández F, Diaz-Romero F, Rodriguez-Moreno F, Martinez-Riera A. Transient hemolytic anemia after transjugular intrahepatic portosystemic stent shunt. HPB Surg 1996; 9 (04) 249-251
    CrossrefPubMedSuche in Google Scholar
  • 15 Fallon E, Ehrenwald E, Nazarian GK, Smith CI. TIPS with a polytetrafluoroethylene-lined stent graft and associated haemolytic anaemia. Gut 2008; 57 (08) 1180-1181
    PubMedSuche in Google Scholar
  • 16 Abraham SA. Reversal of hemolytic anemia and hepatic encephalopathy by transjugular intrahepatic portosystemic shunt occlusion. Curr Treat Options Gastroenterol 2000; 3: 105-109
    CrossrefPubMedSuche in Google Scholar